StockTipsArenaBeta

BUY Piramal Pharma Limited — IDBI Capital

BUYPiramal Pharma Limited

byIDBI CapitalHorizon: NA (inferred Swing (≤2wk))21 Jul 2026via IDBI Capital Research Calls Telegram

Entry₹183Stated
Target₹193
Total upside +5.46% (call closed)
Stop loss₹178-2.73% risk
Exit₹17822 Jul 2026, 9:50 am
Stop-loss hit-2.73%
Follow IDBI Capital for new calls(27% target hit, 184 closed calls)Get alertsWatch PPLPHARMA for new buy/sell callsGet alertsSee 2 active Swing calls on PPLPHARMASee 264 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 22 Jul 2026
2 supporting1 neutral3 opposing
Supports the BUY call (2)

Piramal Pharma, Authum Investment, Vaibhav Global: शेअर बाजारात दिसले 'टेक्निकल ब्रेकआउट'चे संकेत!

NewsGoogle News·20 Jul · 2d ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·27 May · 2mo ago

Neutral / worth noting (1)

Piramal Pharma, Authum Investment, Vaibhav Global Show Technical Breakouts

NewsGoogle News·20 Jul · 2d ago

(opens in new tab)
Weighs against the BUY call (3)

HDFC Mutual Fund reduces stake in Piramal Pharma by 2.005%

NewsGoogle News·18 Jul · 3d ago

(opens in new tab)

HDFC Mutual Fund Sells 2% Stake in Piramal Pharma

NewsGoogle News·17 Jul · 4d ago

(opens in new tab)

HDFC Mutual Fund ने Piramal Pharma मधील हिस्सा विकला, मोठी घट!

NewsGoogle News·17 Jul · 4d ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.